Skip to main content
. 2021 May 28;9(6):1158. doi: 10.3390/microorganisms9061158

Figure 4.

Figure 4

Metabolomic pathway map of Mtb treated with ciprofloxacin. The metabolite markers best describing the variation in the metabolome compared to those of untreated Mtb are represented in bold text with up or down arrows indicating elevated or reduced concentrations, respectively.